CARDIAC CELL VOLUME REGULATION IN CARDIOPLEGIA
心麻痹中的心肌细胞体积调节
基本信息
- 批准号:3365908
- 负责人:
- 金额:$ 18.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-16 至 1995-07-31
- 项目状态:已结题
- 来源:
- 关键词:adenosinetriphosphatase atrial natriuretic peptide bicarbonates calcium cell morphology cell osmotic pressure chlorine heart arrest heart cell heart surgery hydrogen induced hypothermia ion transport laboratory rabbit membrane transport proteins microelectrodes myocardial infarction potassium single cell analysis sodium
项目摘要
Cellular edema is a critical aspect of myocardial injury. Defects in cell
volume regulation are associated with cell damage and contractile and
electrical dysfunction during cardioplegia (elective cardiac arrest),
ischemia and reflow. Despite its importance, volume regulation by cardiac
cells is not well understood. This presents an acute problem for
cardioplegia because the solution perfusing the heart must be designed
provide myocardial protection during arrest.
The goal of these studies is to understand the mechanisms that regulate
cardiac cell volume under cardioplegic and physiologic conditions.
Processes underlying cell volume control will be identified from
measurements of cell volume and determinants of the intracellular ion
activities of K+, Na+, Cl- and H+ with ion-selective microelectrodes (ISE)
in both isolated ventricular myocytes and papillary muscles from adult and
neonatal rabbit hearts. Measurements of cell volume will be made with
three independent methods: (1) video microscopy will 'optically section'
myocytes; (2) volume will be determined from the resistance to current flow
around a single myocyte held in a specially designed pipette; and (3)
changes in cytoplasmic compartment volume will be determined by loading
papillary muscles or myocytes with tetramethylammonium (TMA+) and measuring
the trapped TMA+ with an ISE.
We will: (1) Test the hypothesis that isosmotic cardioplegic solutions are
anisotonic and cause cell volume to change. (2) Evaluate the role of
Na+/K+/2Cl- cotransport, Na+/Cl- cotransport, Na+-K+ pump, Na+-H+ exchange,
Cl--HCO3- exchange, and Na+-Ca2+ exchange in the maintenance of cell volume
under physiologic and cardioplegic conditions and during osmotic stress.
Transport processes will be identified from the effects of transport
inhibitors and selective omission of transported ions from the bathing
media on both cell volume and intracellular ion activities. (3) Assess the
role of mobile anions and the [K+] [Cl-] product in setting cell volume.
(3) Test the hypothesis that cell volume control is different in neonatal
and adult cells. (4) Determine the effect of altering pHi and metabolic
inhibition on cell volume. (5) In a working heart model, compare the
efficacy of standard cardioplegic solutions to that of 'improved' solutions
designed to better regulate cell volume.
The combination of intracellular ion activity measurements with novel
techniques for determining cell volume in isolated myocytes and papillary
muscles can provide unique information about the response of cardiac cells
to perturbations that alter cell volume and allow identification of solute
transport pathways that contribute to regulation of cell volume and,
ultimately, to the integrity of the cell membrane. The significance of
these experiments is that they will provide insight into a basic, critical,
physiological processes that are virtually unexplored in heart. Knowledge
of the factors responsible for cell volume control is a necessary
prerequisite for understanding pathophysiological disturbances of cell
volume, such as those occurring during cardioplegia and infarction.
细胞水肿是心肌损伤的一个重要方面。细胞缺陷
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLIVE M BAUMGARTEN其他文献
CLIVE M BAUMGARTEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLIVE M BAUMGARTEN', 18)}}的其他基金
SWELLING ACTIVATED CURRENTS AND MYOCYTE VOLUME IN CHF
CHF 中的膨胀激活电流和心肌细胞体积
- 批准号:
6630381 - 财政年份:2000
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
2223195 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
2459970 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
2750355 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
6328365 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
6743716 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
6638312 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
CARDIAC CELL VOLUME REGULATION IN HEALTH AND DISEASE
健康和疾病中的心肌细胞体积调节
- 批准号:
6043772 - 财政年份:1991
- 资助金额:
$ 18.41万 - 项目类别:
相似海外基金
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
- 批准号:
10627996 - 财政年份:2022
- 资助金额:
$ 18.41万 - 项目类别:
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
- 批准号:
10419574 - 财政年份:2022
- 资助金额:
$ 18.41万 - 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
- 批准号:
10676800 - 财政年份:2020
- 资助金额:
$ 18.41万 - 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
- 批准号:
10442162 - 财政年份:2020
- 资助金额:
$ 18.41万 - 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
- 批准号:
10472035 - 财政年份:2020
- 资助金额:
$ 18.41万 - 项目类别:
Mitochondria-Mediated Effects and Therapeutic Potential of Atrial Natriuretic Peptide in Salt-Sensitive Hypertension Diversity Supplement
盐敏感性高血压多样性补充剂中心房钠尿肽的线粒体介导作用和治疗潜力
- 批准号:
10337412 - 财政年份:2020
- 资助金额:
$ 18.41万 - 项目类别:
Development of a high-precision diagnostic method for heart failure utilizing abnormal biosynthesis of beta-atrial natriuretic peptide in the failing heart
利用衰竭心脏中β-心房钠尿肽的异常生物合成开发心力衰竭的高精度诊断方法
- 批准号:
20K08414 - 财政年份:2020
- 资助金额:
$ 18.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Atrial natriuretic peptide induces peroxisome proliferator
心钠素诱导过氧化物酶体增殖
- 批准号:
15K10206 - 财政年份:2015
- 资助金额:
$ 18.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.
心房钠尿肽可防止癌症通过血管内皮细胞转移。
- 批准号:
26461393 - 财政年份:2014
- 资助金额:
$ 18.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel strategy for heart failure treatment with recombinant atrial natriuretic peptide-induced cardiac progenitor cells
重组心钠素诱导的心脏祖细胞治疗心力衰竭的新策略
- 批准号:
25461069 - 财政年份:2013
- 资助金额:
$ 18.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




